Zobrazeno 1 - 10
of 190
pro vyhledávání: '"F. Tzortzatou-Stathopoulou"'
Conformational dynamics of the EGFR kinase domain reveals structural features involved in activation
Publikováno v:
Proteins: Structure, Function, and Bioinformatics. 76:375-386
The epidermal growth factor receptor (EGFR) has been the focus of intensive studies because of its importance in cancer research. Thus, a broader understanding of the molecular mechanism of activation of the EGFR kinase will have profound significanc
Autor:
T. Geller, V. Prakash, J. Batanian, M. Guzman, E. Duncavage, T. Gershon, A. Crowther, J. Wu, H. Liu, F. Fang, I. Davis, D. Tripolitsioti, M. Ma, K. Kumar, J. Grahlert, K. Egli, G. Fiaschetti, T. Shalaby, M. Grotzer, M. Baumgartner, M. Braoudaki, G. I. Lambrou, K. Giannikou, V. Millionis, S. A. Papadodima, N. Settas, G. Sfakianos, K. Stefanaki, A. Kattamis, C. A. Spiliopoulou, F. Tzortzatou-Stathopoulou, E. Kanavakis, S. Gholamin, S. Mitra, A. Feroze, M. Zhang, R. Esparza, S. Kahn, C. Richard, A. Achrol, A. Volkmer, J. Liu, J. Volkmer, R. Majeti, I. Weissman, S. Cheshier, K. Bhatia, N. Brown, J. Teague, P. Lo, J. Challis, V. Beshay, M. Sullivan, F. Mechinaud, J. Hansford, M. Z. Arifin, R. H. Dahlan, M. Sobana, P. Saputra, M. T. Tisell, A. Danielsson, H. Caren, R. Bhardwaj, M. Chakravadhanula, C. Hampton, V. Ozals, J. Georges, W. Decker, V. Kodibagkar, A. Nguyen, M. Legrain, M. P. Gaub, E. Pencreach, M. P. Chenard, D. Guenot, N. Entz-Werle, Y. Kanemura, K. Ichimura, T. Shofuda, R. Nishikawa, M. Yamasaki, S. Shibui, H. Arai, J. Xia, A. Brian, R. Prins, C. Pennell, C. Moertel, M. Olin, L. Bie, X. Zhang, M. Olsson, T. Kling, S. Nelander, V. Biassoni, I. Bongarzone, P. Verderio, M. Massimino, R. Magni, S. Pizzamiglio, C. Ciniselli, E. Taverna, M. De Bortoli, A. Luchini, L. Liotta, E. Barzano, F. Spreafico, E. Visse, E. Sanden, A. Darabi, P. Siesjo, S. Jackson, K. Cohen, D. Lin, P. Burger, F. Rodriguez, X. Yao, R. Liucheng, L. Qin, T. Na, W. Meilin, Z. Zhengdong, F. Yongjun, S. Pfeifer, M. Nister, T. D. de Stahl, E. Basmaci, E. Orphanidou-Vlachou, M.-A. Brundler, Y. Sun, N. Davies, M. Wilson, X. Pan, T. Arvanitis, R. Grundy, A. Peet, C. Eden, B. Ju, T. Phoenix, B. Nimmervoll, Y. Tong, D. Ellison, C. Lessman, M. Taylor, R. Gilbertson, V. Folgiero, F. del Bufalo, A. Carai, M. G. Cefalo, A. Citti, S. Rutella, F. Locatelli, A. Mastronuzzi, O. Maher, S. Khatua, W. Zaky, A. Lourdusamy, L. Meijer, R. Layfield, D. T. W. Jones, D. Capper, M. Sill, V. Hovestadt, L. Schweizer, P. Lichter, D. Zagzag, M. A. Karajannis, K. D. Aldape, A. Korshunov, A. von Deimling, S. Pfister, A. Chakrabarty, R. Feltbower, E. Sheridon, H. Hassan, M. Shires, S. Picton, K. Hatziagapiou, F. Tsorteki, K. Bethanis, V. Gemou-Engesaeth, S. N. Chi, P. Bandopadhayay, K. Janeway, N. Pinches, H. Malkin, M. W. Kieran, P. E. Manley, A. Green, L. Goumnerova, S. Ramkissoon, M. H. Harris, K. L. Ligon, U. Kahlert, M. Suarez, J. Maciaczyk, E. Bar, C. Eberhart, R. Kenchappa, N. Krishnan, P. Forsyth, B. McKenzie, A. Pisklakova, G. McFadden, W. Pan, L. Rodriguez, J. Glod, J. M. Levy, J. Thompson, A. Griesinger, V. Amani, A. Donson, D. Birks, M. Morgan, M. Handler, N. Foreman, A. Thorburn, R. R. Lulla, J. Laskowski, J. Fangusaro, A. J. DiPatri, T. Alden, T. Tomita, E. F. Vanin, S. Goldman, M. B. Soares, M. Remke, V. Ramaswamy, X. Wang, F. Jorgensen, A. S. Morrissy, M. Marra, R. Packer, E. Bouffet, N. Jabado, B. Cole, E. Rudzinski, M. Anderson, K. Bloom, A. Lee, S. Leary, G. Leprivier, B. Rotblat, S. Agnihotri, M. Kool, B. Derry, M. D. Taylor, P. H. Sorensen, T. Dobson, E. Busschers, H. Taylor, R. Hatcher, R. Lulla, V. Rajaram, C. Das, V. Gopalakrishnan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e8ac9f4c5ff7abab4aae5bb18f74f4b
https://europepmc.org/articles/PMC4046298/
https://europepmc.org/articles/PMC4046298/
Autor:
M Bafa, George Vartholomatos, Agathocles Tsatsoulis, Maria Andrikoula, F Tzortzatou-Stathopoulou, GT Tsangaris
Publikováno v:
European Journal of Endocrinology. :403-407
OBJECTIVE: The relative expression of the apoptotic protein Fas and the anti-apoptotic protein Bcl-2 were investigated in thyrocytes from patients with non-toxic nodular goiter (NTG, n=20) and Hashimoto's thyroiditis (HT, n=5), who underwent fine-nee
Autor:
F. Tzortzatou-Stathopoulou, Maria Moschovi, Antonios Kattamis, John Vamvoukakis, George Th. Tsangaris, Stelios Grafakos
Publikováno v:
Medical and Pediatric Oncology. 34:153-156
Autor:
D. Arvanitis, A. Xaidara, M. Andrioti, N. Prodromou, F. Tzortzatou-Stathopoulou, Giulio J. D'Angio, Ch. Hadjigeorgi, V. Mikraki, S. Grafacos
Publikováno v:
Medical and Pediatric Oncology. 26:208-214
Autor:
M. S. Riyat, F Tzortzatou-Stathopoulou, K D Waters, M. Al Sheyyab, P S Hartley, M Weinreb, Jillian R. Mann, P B Hesseling, R Rafii, Philip J. R. Day, J W Schneider, K Tiedemann, T Revesz, Chris Mpofu, F. Niggli, F. Raafat, U R El-Safy, A Mangoud, E R A Khalek, A Nyongo, J. E. Powell, F Madanat, J C Barrantes
Publikováno v:
Archives of Disease in Childhood. 74:27-31
Recent studies have suggested that Epstein-Barr virus (EBV) may play a role in the aetiology of Hodgkin's disease. To determine the role of EBV in childhood Hodgkin's disease in different geographical areas, immunohistochemical staining and in situ h
Autor:
M Braoudaki, F Tzortzatou-Stathopoulou
Publikováno v:
Atlas of Genetics and Cytogenetics in Oncology and Haematology.
Review on PYY (peptide YY), with data on DNA, on the protein encoded, and where the gene is implicated.
Publikováno v:
Clinical laboratory. 57(9-10)
This work was undertaken to investigate the efficacy of gefitinib, an EGFR tyrosine kinase inhibitor, in tumor cell lines of the CNS by studying cell proliferation and phosphorylation of the tyrosine kinase domain ofThe study included neuroblastoma (
Autor:
Constantine P. Karakousis, Maria Moschovi, Nikos Pandis, Euthimios Dimitriadis, Kalliopi Karamolegou, F. Tzortzatou-Stathopoulou, Kalliopi Stefanaki, Emmanouil M. Karavitakis
Publikováno v:
Pediatric bloodcancer. 49(3)
Desmoplastic small round cell tumor (DSRCT) is a rare neoplasm with aggressive behavior. Usually it presents as a peritoneal mass, although other cases in various locations have been described. Since less than 10 cases of primary DSRCT in the pleura
Autor:
M, Moschovi, F, Psychou, D, Menegas, G T, Tsangaris, F, Tzortzatou-Stathopoulou, P, Nicolaidou, P, Nikolaidou
Publikováno v:
Pediatric hematology and oncology. 18(6)
Hydroxyurea (HU) is an oral drug that ameliorates the clinical course of sickle cell anemia by ¯ increasing the levels of fetal hemoglobin and decreasing the adhesion of red cells to endothelium. Although HU has minimal short-term toxicity, few d